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Abstract
Background—P wave indices and PR interval from 12-lead electrocardiograms (ECGs) are
predictors of cardiovascular morbidity and mortality, but their repeatability has not been
examined.
Objectives—Determine the short-term repeatability of P wave indices (P axis, maximum P area
and duration, P dispersion and P terminal force in V1) and PR interval.
Methods—Participants (n=63) underwent two standard ECGs at each of two visits, two weeks
apart. We calculated the intra-class correlation coefficient (ICC), weighted Kappa, and minimal
detectable change and difference.
Results—ICCs were 0.93 for PR interval, 0.78 for P axis, 0.77 for maximum P area, and 0.58 for
maximum P duration. Within- and between-visit Kappa were 0.30 and 0.11 for P dispersion, and
0.68 and 0.46 for P terminal force.
Conclusion—Repeatability of PR duration was excellent, that of P wave axis and maximum
area was fair, and maximum P wave duration and terminal force was poor. Repeatability of P
wave dispersion was fair within visit, yet poor between visits. These results illustrate potential
biases when measurement error of some P wave indices is ignored in clinical and epidemiologic
studies.
Introduction
P wave indices and PR interval are simple electrocardiographic markers that could be
derived from resting, standard 12-lead electrocardiograms (ECGs). P wave indices are
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measures of atrial conduction while PR interval represents the conduction throughout both
the atria and atrioventricular node (AV node). A disturbance in conduction from right to left
atrium results in a prolonged P wave duration (1) and heterogeneous conduction patterns of
atrial impulses results in an increased P wave dispersion (2).
Abnormal P wave indices and prolonged PR interval have been predictive of atrial
fibrillation (AF) (2-4), heart failure (5), stroke (6), and all-cause mortality (7, 8). Novel
indices such as P wave area have gained attention and are also predictive of AF (6, 9).
Traditionally, abnormalities in P wave indices have been used to define left and right atrial
enlargement (10), and screen for chronic obstructive pulmonary disease (11) and
emphysema (12, 13).
Despite the emerging renewed interest in P wave indices and PR interval as predictors of
outcomes, the repeatability of these ECG measures has not been sufficiently examined.
Accurate assessment of the reproducibility of P wave indices is critical to their analysis and
interpretation. The aim of this study was to characterize the short-term repeatability, and the
minimal detectable change and minimal detectable difference of P wave indices and PR
interval estimated from standard 12-lead ECGs in a sample of healthy middle-aged adults.
Materials and Methods
Participants
Our analyses included 63 healthy participants aged 45-64 years recruited from Chapel Hill,
NC. Participants were free of diabetes, hypertension, emphysema, chronic obstructive
pulmonary disease, congestive heart failure, renal disease, a pacemaker, and were not taking
class I or III antiarrhythmics. Participants were asked to avoid intense physical activity,
smoking, eating, or drinking alcoholic beverages for 10 hours before the visits. Each
participant underwent two standardized visits between 7:30 to 11:30 am one to two weeks
apart at the University of North Carolina at Chapel Hill General Clinical Research Center
between July and October 2001. Participants provided written informed consent, and the
study was approved by the University of North Carolina at Chapel Hill Institutional Review
Board.
Electrocardiographic methodology
Details of the ECG methodology for this study have been reported elsewhere (14, 15).
Briefly, two 10-second standard 12-lead ECG recordings (ECG1 and ECG2 at the initial
visit and then ECG3 and ECG4 one to two weeks later) were taken after participants rested
for 15 minutes in the supine position. One of four certified technicians obtained the ECGs at
each visit following a standardized protocol used in the Atherosclerosis Risk in
Communities (ARIC) study (16). The participants were breathing freely and were instructed
not to talk during the recording. Technicians positioned the electrodes using the E-V6
Halfpoint Method (17) and a standardized protocol for placing electrodes on women (18).
ECGs were recorded using the MAC PC Personal Cardiograph (Marquette Electronics, Inc.,
Jupiter, FL). The Epidemiology Cardiology Research Center (EPICARE; Wake Forest
School of Medicine, Winston Salem, NC) centrally processed the ECGs using the GE
Snyder et al. Page 2






















Marquette GE 12-SL software 2001 version (GE, Milwaukee, WI). PR interval and P axis
were automatically provided by the software as single global measures. On the other hand, P
duration, area and amplitude in each of the 12-leads were used to calculate maximum P
wave area, maximum duration, dispersion and terminal force in V1. P wave area was
multiplied by 19.52 μV*ms to make values comparable to P wave area measured from non-
GE software (19). P wave dispersion (ms) was calculated as the maximum P wave duration
minus the minimum P wave duration. P wave terminal force (μV*ms) in lead V1 was
calculated from the P' duration of the terminal (negative) part of the P wave in lead V1
multiplied by the P' amplitude in lead V1 (Figure 1). We used the absolute value of the P
wave terminal force values that were all zero or negative.
In the PR interval analysis, we used both unadjusted and heart rate-adjusted PR interval (ms)
using the Soliman and Rautaharju method (20) where heart rate–adjusted PR interval (PRa)
= PR + 0.26 (heart rate − 70) for age < 60 years and PRa = PR + 0.42 (heart rate − 70) for
age 60 years or older. We obtained similar results by both methods, thus PR interval without
adjustment was presented.
Statistical analysis
Summary measures of P wave indices and PR interval for each ECG measurement were
estimated as means and standard deviations (SD). P wave indices with a skewed distribution
were expressed as medians and inter-quartile ranges and log transformed for the analysis.
The average and absolute difference between pairs of measurements (ECG2 - ECG1 and
ECG4 - ECG3) within-and between-visit were calculated (ECG3 - ECG1 and ECG 4 -
ECG2). We excluded ECGs that showed evidence of ectopic ventricular complexes (EVC;
n=3), and excluded one outlying value for P axis (–25°) since it was greater than four
standard deviations away from the mean.
We used a nested random-effects analysis of variance model to parse the variance of the
measures into between-participant (σ2p), between-visit (σ2bv), and within visit-components
(σ2wv), assuming that the between-visit variation is the same for all participants and that the
within-visit variation is the same for all visits and all participants. We calculated the
coefficient of variation as 100 X square root of the variance/grand mean, where the variance
was σ2p , σ2bv, or σ2wv. To estimate the repeatability of the indices, the intra-class
correlation coefficient (ICC) was calculated by dividing the between-participant variance by
the total variance [σ2p/σ2p = σ2p/ σ2p+σ2bv+σ2wv]. Maximum P wave area showed a slightly
skewed distribution, thus we used the log maximum P area to compute the ICC since the
confidence interval is sensitive to departures from normality. We also calculated the
standard error of measurement (SEM) as SEM = √(σ2bv+σ2wv). Since P wave terminal force
and P wave dispersion showed bi-modal distributions, we used the weighted Kappa (Kw) to
evaluate agreement within- and between-visit. Cicchetti-Allison weights (w) were ordered
by quartiles of the variables [Kw = Po(w) – Pe(w)/1-Pe(w)].
To aid in the application of these results to study design development and interpretation of
results, we estimated changes in P wave indices and PR interval based on the variance and
sample size for one- and two-sample study designs. We calculated the minimal detectable
change with 95% confidence between two time points for an individual that reflects true
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change above that of measurement error [MDC95 = SEM*√2*1.96]. For a two-sample study
design, we calculated the minimal detectable difference (MDD) between two measurements
as MDD = [(√2*σ2total)/N]*(tα(df)+tβ(df)). We also calculated the MDD as a percent of the
grand mean. Analyses were performed using SAS, version 9.2 (SAS Institute, Inc., Cary,
NC) and all statistical tests are 2-sided with statistical significance level of P <0.05.
Results
The average age of the participants was 52 years (range 45.1 to 64.6 years old) and the
average body mass index (BMI) was 26.9 kg/m2 (range 19.4 to 42.6 kg/m2; Table 1). There
were 31 (49.2%) females and 20 (31.8%) non-Caucasian participants. The mean values for
PR interval, P axis, maximum P wave area, and maximum P wave duration were consistent
within and between visits, but varied for P wave dispersion and P wave terminal force
(Table 2). The average within-visit difference was smaller than the between-visit difference
for all indices except for P wave axis and maximum P wave duration. The absolute
difference between-visit was greater than the absolute difference within-visit for all indices.
Between-participant variation accounted for the majority of the total variation among all P
wave indices (Table 3). The between-visit variation was higher than the within-visit
variation for PR interval and maximum P wave area, but lower for P axis and maximum P
wave duration. The within-visit coefficient of variation (CV) ranged from 2.9% for PR
interval to 13.7% for P axis, and the between-visit CV ranged from undetectable for
maximum P wave duration to 13.8% for maximum P wave area.
The ICC (95% confidence interval) was 0.93 (0.90, 0.96) for PR interval, 0.78 (0.71, 0.86)
for P axis, 0.77 (0.67, 0.86) for log maximum P wave area, and 0.58 (0.46, 0.70) for
maximum P wave duration (Table 4). For comparison, the ICC for heart rate was 0.84 (0.77,
0.91). The within-visit weighted Kappa (95% confidence limit) was 0.30 (0.16, 0.44) for P
wave dispersion and 0.68 (0.58, 0.78) for P wave terminal force. The between-visit weighted
Kappa was 0.11 (-0.02, 0.25) for P wave dispersion and 0.46 (0.33, 0.58) for P wave
terminal force.
The MDC95 was 20 ms for PR interval, 21° for P wave area, 3,148 μV*ms for P wave area,
and 21 ms for maximum P wave duration (Table 4). As shown in Table 5, the MDD for 50
participants per group was 20 ms for PR interval (12% of the mean), 12° for P wave axis
(23% of the mean), 1,602 μV*ms for P wave area (23% of the mean), and 8 ms for
maximum P wave duration (8% of the mean). Also shown in this table is the gain in
precision for each index achieved by increasing sample size.
Discussion
To our knowledge this study is the first to report the repeatability of P indices and PR
interval from digitized ECGs and automated P wave calculations. Our analysis showed that
among healthy adults, the repeatability of PR duration is excellent, that of P wave axis and
maximum area is fair, and maximum P wave duration and terminal force is poor.
Repeatability of P wave dispersion is fair within visit, yet poor between visits.
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Previous studies have focused on the within- and between-observer reproducibility of
maximum P wave duration and P wave dispersion from manual or semi-automatic
measurements. One such study reported that the intraobserver ICC for maximum P wave
duration was 0.80 and the ICC for P wave dispersion was 0.82 (21). The interobserver ICC
for maximum P wave duration was 0.56 and the ICC for P wave dispersion was 0.70.
However, a single lead acquisition method was used that is less accurate than a simultaneous
lead acquisition with digital ECGs. Simultaneous lead acquisition allows for a more accurate
determination of the on-set and off-set of the P wave signals (22).
Current technology allows for highly repeatable, automated measurement of P wave indices,
which was used in this analysis. Andrikopoulos et al. showed that a computer based semi-
automatic method had lower relative errors for maximum P wave duration and P wave
dispersion compared to manual methods (23). The interobserver relative errors were 7.8 ±
5.3% for maximum P wave duration and 14.4 ± 6.4% for P wave dispersion. The
intraobserver relative errors were 7.3 ± 5.4% for maximum P wave duration and 12.6 ±
6.7% for P wave dispersion.
Our study design used participant and visit to estimate the variance for each P wave index to
quantify intra-individual variability (sum of the within- and between-visit variation) and
inter-individual variability (between-participant variation) in these indices. The resulting
model was as follows: Yijk=μ + Pi + Vj(i) = ek(ij) where Y = the P wave index, μ = the
intercept, i = 1,2,3 to the 63rd participant, j =visit one or visit two, and k = the first or second
ECG recording, with the assumption that the means of the P wave index do not vary by visit
or by order within visit. As expected, the majority of the variation occurred between-
participants. In our random-effects analysis of variance models, the between-visit variation
represents the additional variation that is added when the ECGs are repeated a week apart
above that of the variation that occurs when the ECGs are repeated two minutes apart
(within-visit). For PR interval and maximum P wave area, the within-visit variation was
lower than the between-visit variation suggesting that more variation was added between-
visits. For P axis and maximum P wave duration, the within-visit variation was higher than
the between-visit variation suggesting that little variation was added when relating two
ECGs from different visits compared to relating ECGs from the same visit.
The between-participant, between-visit and within-visit variation we observed in PR interval
and P wave indices could be attributed to biological variation in cardiac electrophysiology,
measurement error, technical factors, electrode positioning, and environmental factors. The
morphology of the P wave may also contribute to the variation in these measures. Because
of the small magnitude of the P wave signal, greater variability might be inherent when
determining area from low amplitude short P waves. Although digital ECGs allow for more
accurate measurement of the P wave, the onset- and off-set of P waves can be difficult to
define.
The estimates of the SEM, MDC95, and MDD for PR interval and P wave indices we report
can aid in estimating sample sizes and in the evaluation whether differences in P wave
indices are meaningful or statistically significant within participants or between participant
groups. The MDC95 for PR interval was 20 ms suggesting that a change of more than 20 ms
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may be necessary in order to determine whether a change in PR interval exceeds
measurement error and intraindividual variability. A 20 ms change in PR interval may be
clinically relevant as Magnani et al. reported that a 29 ms increase in PR interval conferred a
13% increase in the 10-year risk of heart failure and incident AF (5).
For the MDD, we show the relation between group size and measurement precision. From
this, clinical and population researchers can assess optimal study sizes and possible trade-
offs between precision and the costs associated with additional measurements. Given the
low repeatability of some P wave indices, attempts to increase the precision of P wave
indices by repeating measures, standardizing procedures, and assembling larger sample sizes
should be considered. Otherwise, procedures to adjust for measurement error may be
required. P wave indices also could be used in combination as shown by Altunkeser et al. in
the multivariate prediction of AF from prolonged P wave duration and increased P wave
dispersion (24).
ECG-based indices are extensively used in clinical practice, clinical trials, and to evaluate
the cardiac safety of drugs. At present, the QT interval is a gold standard measure of cardiac
safety used by The Food and Drug Administration (FDA). In some cases, the FDA evaluates
PR interval elongation when reviewing clinical trial data. P wave indices may serve as
additional indicators of cardiac safety since they represent a cardiac electrophysical
biomarker of AV conduction. A maximum P wave duration of ≥ 110 ms (25) and ≥ 120 ms
(26) have been used as a threshold for identification of conduction delays, and a P wave
dispersion ≥ 40 ms has been used as a marker of non-uniform atrial conduction (25).
In addition to the application to cardiac safety, P wave indices also have potential in risk
stratification for AF and pulmonary disease. P wave dispersion has been shown to be a
predictor of the progression from paroxysmal to persistent AF (27), and PR interval was
associated with the risk of heart failure and AF (5). P wave terminal force has been shown to
be a marker of pressure and volume overload in the left atrium (9) and a marker for left
atrial enlargement (10). P axis has been associated with chronic obstructive pulmonary
disease (11) and emphysema (12), while a threshold of >60° has been used to screen for the
latter (28).
Our analysis is limited to short-term repeatability, estimated from ECG measurements at
only two time points. ECGs controlled for respiration phase sampled at rates as high as 1200
Hz would be ideal for ascertaining the on- and off-set of the P wave. ECGs in our study
were originally sampled at 250 Hz with participants breathing freely; as such, it does not
represent the ideal situation but mimics typical clinical practice and research settings.
Accounting for respiration and increasing the sampling rate would likely improve the
repeatability of the P wave indices. Another limitation is that our study design did not allow
for an accounting of technician variation. However, the variance due to technician is likely
negligible as reported for heart rate variability in Schroeder et al. (14) and for spatial T-wave
axis and QT interval in Vaidean et al. (15), consistent with our use of a standardized
protocol and study procedures designed to minimize measurement variability. In a
sensitivity analysis, we obtained the same results when we excluded individuals who
deviated from the protocol at either visit. It is also important to note that the calculations for
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the SEM and MDC assume that the measurement error and detectable change is constant
across the range of values.
PR interval and P wave indices represent widely used biomarkers to detect abnormal atrial
and AV nodal conduction which have implications for clinical research and risk
stratification. The excellent repeatability of PR interval supports its use in clinical and
epidemiologic studies, but there is a potential for bias when such studies ignore the error
with which other P wave indices are measured. Further investigation is needed to tell
whether a change in PR interval and P wave indices are clinically meaningful, but we offer
estimates to aid in interpreting these measurements.
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Illustration of P wave terminal force in lead V1
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Table 1
Participant characteristics of the ECG repeatability study (N=63)
Characteristic Mean ± SD No. (%)
Age 52.0 ± 5.1
Body mass index




    Anticholinergic 5 (7.9)
    Beta-Blocker 1 (1.6)
    Diuretic 4 (6.4)
    Selective serotonin reuptake inhibitor (SSRI) 10 (15.9)
    Sympathomimetic 4 (6.4)
    Thyroid medication 3 (4.8)





Protocol deviation defined as eating, drinking beverages other than water, or smoking <10 hours before the study; SD: standard deviation
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Table 4
ICCs and 95% CIs for P wave indices
Index ICC (95% CI) SEM MDC95
PR Interval (ms) 0.93 (0.90, 0.96) 7.33 20.31
P-axis (°) 0.78 (0.71, 0.86) 7.75 21.47
Maximum P wave area (μV*ms) 0.73 (0.63, 0.84) 1,135.64 3,147.83
Log maximum P wave area (μV*ms) 0.77 (0.67, 0.86) 0.06 0.18
Maximum P wave duration (ms) 0.58 (0.46, 0.70) 7.50 20.78
ICC: Intraclass Correlation Coefficient; SEM: Standard Error of Measurement; MDC95: Minimal Detectable Change
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